Genetic Dissection of Marfan Syndrome and Related Connective Tissue Disorders: An Update 2012
Author(s) -
Sabine Hoffjan
Publication year - 2012
Publication title -
molecular syndromology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.609
H-Index - 36
eISSN - 1661-8777
pISSN - 1661-8769
DOI - 10.1159/000339441
Subject(s) - marfan syndrome , connective tissue , fibrillin , medicine , connective tissue disorder , ehlers–danlos syndrome , aortic dissection , dissection (medical) , aortic aneurysm , pathology , differential diagnosis , genetic counseling , genetic heterogeneity , phenotype , bioinformatics , gene , aneurysm , genetics , anatomy , radiology , biology , aorta
Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue characterized by early development of thoracic aortic aneurysms/dissections together with symptoms of the ocular and skeletal systems. While most patients/families with a classic phenotypic expression of MFS harbour mutations in the gene encoding fibrillin-1 (FBN1), genetic studies of the recent years revealed that the clinical features, as well as the mutated genes, show a high degree of overlap between MFS and other connective tissue diseases (e.g. Loeys-Dietz syndrome, Ehlers-Danlos syndrome, familial thoracic aneurysms and dissections and others). We summarize herein the current knowledge about the wide spectrum of differential diagnoses and their genetic background as well as novel therapeutic approaches in order to provide appropriate counselling and clinical follow-up for the patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom